European Medicines Agency (EMA) has claimed that the weight loss pill 'Reductil' apparently contains an ingredient that increases blood pressure. That increases the risk of heart attacks and stroke.
Also, the Sibutramine Cardiovascular Outcome Trial (SCOUT) surveyed 10,000 patients over six years to reach the conclusion.
New Obesity Guidelines Will Trouble US Children
An article published said: US’s new guidelines on obesity finalized to cause harm to children, who are to be classified as obese and overweight.
An article published said: US’s new guidelines on obesity finalized to cause harm to children, who are to be classified as obese and overweight.
"This is information we need to take very seriously because we should not be prescribing it to the wrong people," the Daily Express quoted Dr David Haslam, chair of the National Obesity Forum, as saying.
He added: "Anything that lapses blood pressure control could have side-effects.
Anti-obesity Drug?s Claimed Additional Benefits on ?cardiometabolic Risk Factors? Questioned
Additional beneficial effects on ‘cardiometabolic risk factors’ beyond those expected from weight loss in trials of the anti-obesity drug
Additional beneficial effects on ‘cardiometabolic risk factors’ beyond those expected from weight loss in trials of the anti-obesity drug
Also, an EMA spokesman said: "Because of the seriousness of the findings of the SCOUT study, the Committee for Medicinal Products for Human Use is currently assessing the implications of these findings for the use of sibutramine in normal clinical practice."
Advertisement
"Sibutramine is an important treatment for patients who are obese."
Advertisement
FDA Warns Against Buying of Counterfeit Drug Through Internet
The FDA has warned the consumer against the multiple sites that sell counterfeit prescription drugs.
The FDA has warned the consumer against the multiple sites that sell counterfeit prescription drugs.
Source-ANI
TRI
